Korean J Dermatol.
2007 Feb;45(2):200-202.
A Case of Pompholyx after Intravenous Immunoglobulin Therapy
- Affiliations
-
- 1Department of Dermatology, Hanyang University College of Medicine, Seoul, Korea. romio@hanyang.ac.kr
Abstract
- Intravenous immunoglobulin therapy has been used to treat various immune-mediated diseases. Its utility in dermatology continues to expand, including treatment for autoimmune blistering disease, graft-versus-host disease, and dermatomyositis. It is generally considered safe, and serious adverse effects such as anaphylaxis, renal tubular necrosis or aseptic meningitis rarely occur. Furthermore, adverse skin reactions very rarely occur, but can include urticaria, pruritus, eczema, alopecia, lichenoid dermatitis or pompholyx. We describe a case of a 48-year-old man who developed vesicular eczema on his palms and soles after administration of intravenous immunoglobulin therapy for encephalomyelopathy.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of Pompholyx Following Intravenous Immunoglobulin Therapy in Guillain-Barre Syndrome
- Pompholyx and Eczematous Reaction After Intravenous Immunoglobulin Therapy for Patient with Guillain-Barré Syndrome
- A Case of Cerebral Infarction Following Intravenous Immunoglobulin Therapy in a Patient with Guillain-Barre Syndrome
- Helpful Clinical Features for Differential Diagnosis of Palmoplantar Pustulosis and Pompholyx
- A case of intravenous immunoglobulin therapy in severe aspirin - sensitive asthma patient combined with IgG1 and IgG3 subclass deficiency
